At a glance
- Originator Eli Lilly and Company
- Class Anxiolytics; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Irritable bowel syndrome; Major depressive disorder; Male sexual dysfunction
Most Recent Events
- 01 Apr 1999 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 01 Apr 1999 No-Development-Reported for Depression in USA (Unknown route)
- 01 Apr 1999 No-Development-Reported for Irritable bowel syndrome in USA (Unknown route)